13.07.2015 Views

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Medical</strong> <strong>Aspects</strong> <strong>of</strong> <strong>Chemical</strong> <strong>Warfare</strong>INTRODUCTIONIn 600 b c e, soldiers <strong>of</strong> the Greek king Solon induceddebilitating diarrhea in enemy troops by throwinghighly poisonous hellebore roots into streams supplyingtheir water. Today, scientists seeking new nonlethalincapacitating substances are studying neuropeptidesand neuromodulators. Both then and now, the goal hasbeen to weaken an enemy without the use <strong>of</strong> lethalforce. In the last half-century, “incapacitating agent”has become the accepted military term for such unconventionalweapons.According to the US Department <strong>of</strong> Defense, an incapacitatingchemical agent falls into the more generalcategory <strong>of</strong> nonlethal weapons (NLWs) and thereforeshares the following characteristics:[Non-lethal weapons] are explicitly designed andprimarily employed so as to incapacitate personnelor materiel, while minimizing fatalities, permanentinjuries to personnel, and undesired damage to propertyand the environment.Unlike conventional lethal weapons that destroytheir targets principally through blast, penetrationand fragmentation, non-lethal weapons only employmeans other than gross physical destruction to preventthe target from functioning.Non-lethal weapons are intended to have one, orboth, <strong>of</strong> the following characteristics:1. <strong>The</strong>y have relatively reversible effects on personnelor materiel.2. <strong>The</strong>y affect objects differently within their area <strong>of</strong>influence. 1Use <strong>of</strong> an incapacitating agent by conventionalmilitary forces would face political, military, medical,and budgetary constraints. Factors such as effectiveness,relative lack <strong>of</strong> toxicity or excessive persistence,logistical feasibility, predictability <strong>of</strong> behavior, manageability<strong>of</strong> casualties, availability <strong>of</strong> antidotes,limitations imposed by treaties, and cost would needto be considered. No proposed incapacitating agenthas yet been acceptable. 2 Further considerationswould come into play before any decision to deployan agent. Methods and equipment must be designedto manufacture, store, and transport the agent.Troops in the field would require extensive trainingto operate what might be a complex delivery system.<strong>Medical</strong> personnel would need to learn how best totreat the casualties, working within the confines <strong>of</strong>the battlefield.This chapter reviews the properties <strong>of</strong> many possiblechemical incapacitating agents, as well as a fewthat are physical in nature, and their diagnosis, treatment,and general principles <strong>of</strong> management.HISTORY AND MODERN DEVELOPMENTAlthough few references to the historical use <strong>of</strong>drugs for military purposes appear in contemporarypublications, a substantial literature describes a variety<strong>of</strong> tactical efforts to incapacitate enemy forces withmind-altering chemicals. <strong>The</strong> rarity <strong>of</strong> new publicationsabout the incapacitating chemical agents consideredmost promising can be attributed in part to theexponential acceleration <strong>of</strong> pharmaceutical discovery,which has eclipsed interest in many drugs used widelyin the past. In addition, computerized databases tendto include only research reports published since 1970.Consequently, the current focus is on new drugs tailoredto specific nervous system targets. <strong>The</strong> “newage” neurochemicals under consideration are notnew—they incorporate advances in neuropharmacologybut no new modes <strong>of</strong> action; some are even lesspractical than those proposed in the 1960s. Even theagents attracting interest in the 1960s were not as newas they seemed.In 1961 Ephraim Goodman, a psychologist in theEdgewood <strong>Medical</strong> Laboratories, Maryland, systematicallyreviewed 100 years <strong>of</strong> reports and letters appearingin four leading American and British medicaljournals (as well as a more limited number <strong>of</strong> severalrespected German medical periodicals). Goodmandiscovered numerous reports <strong>of</strong> deliberate administration,particularly <strong>of</strong> atropine and related drugs,to produce “behavioral toxicity” (a term introducedby Joseph Brady in 1956). Often, these substanceswere used by single individuals, but some can beconsidered examples <strong>of</strong> drugs used as “weapons <strong>of</strong>mass destruction” or “mass casualty weapons.” <strong>The</strong>following excerpts from Goodman’s review showthat incapacitating agents are not a new approach tomilitary conflict:According to Sextus Julius Frontinus, Maharbal, an<strong>of</strong>ficer in Hannibal’s army about 200 b c e, …. sent bythe Carthaginians against the rebellious Africans,knowing that the tribe was passionately fond <strong>of</strong>wine, mixed a large quantity <strong>of</strong> wine with mandragora,which in potency is something between a poisonand a soporific. <strong>The</strong>n, after an insignificant skirmish,he deliberately withdrew. At dead <strong>of</strong> night, leavingin the camp some <strong>of</strong> his baggage and all the druggedwine, he feigned flight. When the barbarians capturedthe camp and in frenzy <strong>of</strong> delight greedily drank the412

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!